Xenofocus rises 7.31% amid surge in gene therapy/analysis themes

On the 19th, the gene therapy/analysis theme showed strength, rising 4.19% compared to the previous day, while Genofocus, a related stock attracting attention, surged 7.31% from the previous day. Genofocus is known as an enzyme specialist company.

[Graph] Major stock price changes in the gene therapy/analysis theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Genofocus’s quant financial score is 15.49 points, ranking 8th within the gene therapy/analysis theme, with higher growth and stability scores than the average of other related stocks. This indicates that compared to other stocks in the theme, Genofocus’s sales and net income growth rates are relatively fast, and its ability to respond to changes in domestic and international economic environments is also good.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.